RNA-guided specificity enables customization to diverse cancer transcripts, offering potential for personalized precision medicine with reduced collateral damage.

A Nature 2026 study reports a CRISPR-Cas12a2–based method that uses RNA guidance to target cancer-specific transcripts, specifically mutant p53, triggering trans-nucleolytic chromatin shredding to rapidly kill cancer cells while sparing normal tissue.

The work signals a shift toward scalable genetic medicines with potential to multiplex and address multiple cancer mutations, and even others areas like virus-infected or aging-affected cells.

Jennifer A. Doudna serves as the correspondence author for study communications and inquiries.

Researchers aim to improve delivery efficiency to tumors and expand testing across brain, prostate, and ovarian cancers through ongoing collaborations.

Ongoing challenges include delivering Cas12a2 and guide RNAs in vivo, with exploration of viral vectors, lipid nanoparticles, and other delivery methods.

The study combines RNA recognition with chromatin-level genome manipulation, aiming to selectively disrupt cancer-associated genetic alterations.

Nature published this 2026 study with a timeline: submission in early November 2025, acceptance in late May 2026, and publication on June 8, 2026.

By targeting RNA footprints of undruggable mutations such as p53, the approach bypasses the need for druggable protein pockets, aiming at roughly 40–50% of human tumors.

Proof-of-concept experiments in cell lines and tumor organoids show selective elimination of cells harboring mutant p53 transcripts with minimal impact on normal cells, indicating a therapeutic window.

Overall, the research emphasizes shifting from protein-targeted approaches to exploiting RNA signatures that trigger genome-wide chromatin destruction as a therapeutic strategy.

The article provides extensive supplementary materials and data, including uncropped gels, reporting summaries, gRNA and oligo catalogs, substrates, cell lines, plasmids, and a peer review file.